Cited by 22Coronary Interventions and DiagnosticsAcute Myocardial Infarction ResearchAntiplatelet Therapy and Cardiovascular Diseases

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Device Thrombosis with Bioresorbable Scaffolds

Mukherjee, Debabrata·2017·New England Journal of Medicine

Abstract

The development of coronary-artery stents was a major advance in interventional cardiology. However, conventional stents, which are metallic, cage-like structures, have some limitations — notably, they leave a permanent implant, which may prevent favorable arterial remodeling and preclude future surgical revascularization. Bioresorbable scaffolds were developed to overcome some of the disadvantages of metallic stents in that they gradually degrade in the body over time and leave no residual implant.1 The Absorb everolimus-eluting bioresorbable vascular scaffold (Abbott Vascular) was approved for use by the Food and Drug Administration (FDA) in July 2016.The largest trial of the Absorb bioresorbable scaffold was . . .

Overview

Integrity signals

Registry

Crossref · 10.1056/nejme1703202

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Mukherjee D. Bioabsorbable stents. In: Topol EJ, Teirstein PS, eds. Textbook of interventional cardiology. 6th ed. Philadelphia: Saunders, 2011:432-441.

Cited by

Sorted by citations

Metadata

Authors
Mukherjee, D.
Affiliations
Texas Tech University Health Sciences Center (US)
Corresponding author
Mukherjee, Debabrata
Venue
New England Journal of Medicine
Published
2017-06-15
Volume
376
Issue
24
Pages
2388-2389
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2601973560
Cited by
22
References
6
Citations by year
2026: 1 · 2025: 1 · 2022: 4 · 2021: 5 · 2019: 3 · 2018: 3 · 2017: 5
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords
device thrombosis, bioresorbable vascular scaffolds, Absorb scaffold, everolimus-eluting stent, coronary stents, arterial remodeling, revascularization, percutaneous coronary intervention
MeSH terms
Humans, Thrombosis, Absorbable Implants, Drug-Eluting Stents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review